Research Article
A Cost Effective (QbD) Approach in the Development and Optimization of Rosiglitazone Maleate Mucoadhesive Extended Release Tablets – In Vitro and Ex Vivo
Suryaprakash Reddy Chappidi 1 
, Eranti Bhargav 1 * , Venkataranganna Marikunte 2, Haranath Chinthaginjala 3 , Mallela Vijaya Jyothi 3 , Muralidhar Pisay 3, Mounika Jutur 3 , Mujahid Shaik Mahammad 3, Mrunalini Poura 3, Sailaja Yadav 3, Moinuddin Syed 3
Cited by CrossRef: 13
1- Teaima M, Abdel Hamid M, Shoman N, Jasti B, El-Nabarawi M. Promising Swellable Floating Bupropion Tablets: Formulation, in vitro/in vivo Evaluation and Comparative Pharmacokinetic Study in Human Volunteers
. DDDT. 2020;Volume 14:2741 [Crossref]
2- JONNA S, BAPATU H, SUBBAPPA P, SARAVANAN K. A QBD WITH THE FRACTIONAL FACTORIAL DESIGN WAS USED TO MATCH THE SIMILARITY BETWEEN RANOLAZINE EXTENDED-RELEASE TABLETS 500 MG AND 1000 MG. Int J App Pharm. 2023;:98 [Crossref]
3- Ibnidris A, Liaskos N, Eldem E, Gunn A, Streffer J, Gold M, Rea M, Teipel S, Gardiol A, Boccardi M. Facilitating the use of the target product profile in academic research: a systematic review. J Transl Med. 2024;22(1) [Crossref]
4- Torregrosa A, Ochoa-Andrade A, Parente M, Vidarte A, Guarinoni G, Savio E. Development of an emulgel for the treatment of rosacea using quality by design approach. Drug Development and Industrial Pharmacy. 2020;46(2):296 [Crossref]
5- Shah V, Khambhla E, Nivsarkar M, Trivedi R, Patel R. An Integrative QbD Approach for the Development and Optimization of Controlled Release Compressed Coated Formulation of Water-Soluble Drugs. AAPS PharmSciTech. 2022;23(5) [Crossref]
6- Komati S, Swain S, Rao M, Jena B, Dasi V. Mucoadhesive Multiparticulate Drug Delivery Systems: An ExtensiveReview of Patents. Adv Pharm Bull. 2019;9(4):521 [Crossref]
7- Mahmood T, Sarfraz R, Ismail A, Ali M, Khan A. Pharmaceutical Methods for Enhancing the Dissolution of Poorly Water-Soluble Drugs. ASSAY and Drug Development Technologies. 2023;21(2):65 [Crossref]
8- Jankowska A, Wesołowska A, Pawłowski M, Chłoń-Rzepa G. Diabetic Theory in Anti-Alzheimer’s Drug Research and Development - Part 1: Therapeutic Potential of Antidiabetic Agents. CMC. 2020;27(39):6658 [Crossref]
9- Mehrotra S, Mehrotra S, Kumar L.
Implementation of Quality by Design in the Formulation and Development of Nanocarrier-Based Drug Delivery Systems
. Crit Rev Ther Drug Carrier Syst. 2023;40(3):1 [Crossref]
10- Mishra S, Yadav K, Prabhakar B. Application of quality by design approach to examine the effect of nanocrystalline cellulose extracted from agricultural waste as a disintegrant. Chem Pap. 2023;77(11):7197 [Crossref]
11- Simão J, Chaudhary S, Ribeiro A. Implementation of Quality by Design (QbD) for development of bilayer tablets. European Journal of Pharmaceutical Sciences. 2023;184:106412 [Crossref]
12- Sousa A, Serra J, Estevens C, Costa R, Ribeiro A. A quality by design approach in oral extended release drug delivery systems: where we are and where we are going?. J Pharm Investig. 2023;53(2):269 [Crossref]